MPI 5011
Alternative Names: Fluorouracil therapeutic implant; IntraDose-FULatest Information Update: 20 Feb 2006
At a glance
- Originator Chiron Corporation
- Class Antineoplastics
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Head and neck cancer; Liver cancer; Prostate cancer
Most Recent Events
- 31 Dec 1998 Suspended-II for Liver cancer in USA (Intratumoural)
- 31 Dec 1998 Suspended-II for Prostate cancer in USA (Intratumoural)
- 31 Dec 1998 Suspended-III for Head and neck cancer in USA (Intratumoural)